Actavia Life Sciences, Inc. (RASP)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0285 (-87.69%)
At close: Jul 22, 2024
Actavia Life Sciences Market Cap
Actavia Life Sciences has a market cap or net worth of $3.09 million as of May 12, 2025. Its market cap has decreased by -96.98% in one year.
Market Cap
3.09M
Enterprise Value
3.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 14, 2016, Actavia Life Sciences's market cap has decreased from 71.15M to 3.09M, a decrease of -95.66%. That is a compound annual growth rate of -33.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 568.98M |
| CytoDyn | 497.14M |
| Glass House Brands | 478.11M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |